Skip to main content
Equibles

SAILIFE · Sai Life Sciences Limited

Use SAILIFE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SAILIFE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,929.00 INR +24.45 (+1.28%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 123.33K Avg daily vol (3M) 93.88K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,929.00 INR Open1,834.95 INR Day1,825.55–1,955.00 INR 52W close796.40–1,929.00 INR Avg vol 30d153K Last earningsNov 6, 2026 DataDec 2024–Nov 2026

Latest documents

2026
Nov 6
Earnings call
Q2 FY27 revenue rises 23% as EBITDA margin holds at 28%

Sai Life Sciences Limited reported Q2 FY27 revenue growth of 23% year-on-year and a 28% EBITDA margin. Capex reached INR621 crores in the first six months of fiscal '27; a 225 KL expansion moved to early Q3 of fiscal '28.

5 source passages
welcome to Sai Life Sciences Limited Q2 FY27 Earnings Conference Call. For Q2 FY27, our revenues grew by 23% year-on-year EBITDA for the quarter was 28% of the revenue and was in line with the year-on-year margin trajectory. we have incurred expenditure of approximately INR621 crores during the first six months of fiscal '27, of which INR358 crores was incurred in Q2. the commissioning of the additional capacity of 225 KL is now expected to be available by early Q3 of fiscal '28, compared with our earlier timelines. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
· 4.40B INR 0 INR '25 Q3 · 5.80B INR 882.69M INR '25 Q4 · 4.96B INR 604.55M INR '26 Q1 · 5.37B INR 0 INR '26 Q2 ▲26.5% 5.56B INR 0 INR '26 Q3 ▲3.9% 6.02B INR 1.04B INR '26 Q4 ▲11.7% 5.54B INR 0 INR '27 Q1 LATEST ▲22.5% 6.59B INR 983.17M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 796.40 INR Now 1,929.00 INR · 100% Range high 1,929.00 INR
vs 200-day avg +56% vs 50-day avg +23%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:SAILIFE +8.1% +38.2% +74.8% +23.7% +112.7%

Exchange listing

Market
XBOM
Ticker
SAILIFE
ISIN
INE570L01029
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.sailife.com/
Investor relations
https://www.sailife.com/investors/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-06 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-07 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-15 Audio Transcript
    Sai Life Sciences Limited Q4 FY26 Earnings Conference Call
  • Earnings call · Q3 2026 2026-02-06 Audio Transcript
    Sai Life Sciences Limited Q3 FY ‘26 Earnings Conference Call